Pharmacie Centrale DES Hopitaux (PC Pharmaceutical Import Profile — Algeria (DGFT 2022–2026)

Name: Pharmacie Centrale DES Hopitaux (PC Pharmaceutical Import Records from India — 4 Products, $672.6K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Pharmacie Centrale DES Hopitaux (PC — Pharmaceutical Importer Profile (2026) | 4 Products, $672.6K Trade | TransData Nexus

Import Portfolio — Top 4 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Epirubicin	Advanced Oncology	$250.0K	5	3.9%	3
2	Mitomycin	Advanced Oncology	$200.0K	4	2.5%	4
3	Vincristine	Oncology	$122.6K	8	6.0%	2
4	Cisplatin	Oncology	$100.0K	2	0.8%	11

Pharmacie Centrale DES Hopitaux (PC imports 4 pharmaceutical products across 2 categories into Algeria totaling $672.6K.

Pharmacie Centrale DES Hopitaux (PC — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Pharmacie Centrale des Hôpitaux (PCH) is an Algerian Public Establishment with Industrial and Commercial Character (EPIC), operating under the Ministry of Health. Established to supply pharmaceutical products to public health institutions across Algeria, PCH plays a pivotal role in the nation's healthcare system. The company manages a diverse portfolio of over 1,000 pharmaceutical product references, ensuring the availability of essential medications in public health facilities. (pch.dz)

Headquartered in Dar el Beida, Algiers, PCH's distribution network spans five regions: Algiers, Oran, Annaba, Biskra, and Bechar. This extensive coverage facilitates efficient delivery and storage of pharmaceutical products, meeting the needs of various healthcare establishments. The company collaborates with approximately 250 suppliers, including 89 local and 158 foreign entities, to source a wide range of pharmaceutical products. (pch.dz)

2Distribution Network

PCH's distribution network is strategically designed to ensure the timely and efficient delivery of pharmaceutical products across Algeria. With warehouses located in Algiers, Oran, Annaba, Biskra, and Bechar, the company maintains a robust logistics infrastructure capable of handling a diverse range of pharmaceutical products. This geographic coverage enables PCH to serve a wide array of healthcare facilities, including hospitals, clinics, and pharmacies, ensuring that essential medications are readily available nationwide. (pch.dz)

3Industry Role

As a key supplier to public health institutions, PCH serves as a primary wholesaler and distributor of pharmaceutical products in Algeria. The company's clientele includes 621 public health establishments and 1,396 diverse clients, highlighting its significant presence in the Algerian pharmaceutical supply chain. By managing a comprehensive portfolio of over 1,000 pharmaceutical product references, PCH ensures the consistent availability of essential medications, thereby supporting the healthcare system's operational needs. (pch.dz)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Pharmacie Centrale DES Hopitaux (PC

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

PCH's import data indicates a diversified sourcing strategy, with shipments from multiple suppliers across different countries. This approach mitigates the risks associated with single-source dependency, ensuring a stable and reliable supply chain. The company's import portfolio includes a variety of pharmaceutical products, reflecting a strategic choice to maintain flexibility and adaptability in its procurement processes. The shipment data suggests a stable relationship with suppliers, as evidenced by the consistent import volumes and product diversity over the years.

2Supply Chain Resilience

PCH's supply chain demonstrates resilience through its diversified sourcing strategy, engaging with multiple suppliers from various countries. This approach reduces the impact of potential disruptions from any single supplier or region. The company's focus on maintaining a diverse product portfolio further enhances its adaptability to changing market conditions and healthcare needs. While specific details about backup suppliers and shipping routes are not publicly disclosed, PCH's established relationships with a broad network of suppliers and its extensive distribution network suggest a well-structured and resilient supply chain. (pch.dz)

Strategic Implications

Importing Pharmaceuticals into Algeria — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Algeria

1Regulatory Authority & Framework

In Algeria, the regulatory authority overseeing pharmaceutical imports is the Ministry of Health, which sets the standards and regulations for the importation, distribution, and sale of pharmaceutical products. Key legislation governing pharmaceutical imports includes the Pharmaceutical Code, which outlines the requirements for marketing authorization, quality control, and distribution practices. The marketing authorization pathway for Indian generics involves obtaining approval from the Ministry of Health, ensuring that imported products meet the necessary safety, efficacy, and quality standards.

2Import Licensing & GMP

Import licensing requirements in Algeria stipulate that pharmaceutical products must be registered with the Ministry of Health before being imported and distributed. Manufacturers must provide evidence of Good Manufacturing Practice (GMP) compliance, with certifications from recognized authorities such as the European Union (EU) GMP, World Health Organization (WHO) GMP, or Pharmaceutical Inspection Co-operation Scheme (PIC/S) being acceptable. Additionally, wholesalers like PCH must obtain authorization from the Ministry of Health to distribute pharmaceutical products within Algeria.

Quality & Labeling

Pharmacie Centrale DES Hopitaux (PC — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

PCH's focus on importing finished pharmaceutical formulations, particularly in the oncology therapeutic area, aligns with the growing demand for cancer treatments in Algeria. The top five imported products—Epirubicin, Mitomycin, Vincristine, and Cisplatin—are essential chemotherapy agents used in various cancer therapies. This strategic focus addresses the critical need for effective oncology treatments in the country, supporting the healthcare system's capacity to manage cancer cases.

2Sourcing Profile

PCH's sourcing strategy emphasizes the importation of generic drugs, particularly finished formulations, to provide cost-effective treatment options for patients. The company's preference for finished formulations over active pharmaceutical ingredients (APIs) indicates a focus on ready-to-use products that meet the therapeutic needs of healthcare providers. India's established reputation for producing high-quality generic pharmaceuticals positions it as a key supplier in PCH's procurement strategy.

3Market Positioning

PCH serves a diverse segment of the Algerian pharmaceutical market, including public hospitals, clinics, and other healthcare facilities. By supplying essential medications, particularly in the oncology sector, PCH plays a crucial role in ensuring that these institutions have access to necessary treatments. The company's extensive distribution network and strategic sourcing decisions enable it to meet the varied needs of Algeria's healthcare providers effectively.

Seller's Guide — How to Become a Supplier to Pharmacie Centrale DES Hopitaux (PC

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with PCH, given the company's ongoing need for high-quality pharmaceutical products, especially in the oncology therapeutic area. Potential gaps in PCH's current sourcing may include specific formulations or dosages not currently available through existing suppliers. Indian exporters can explore these opportunities by offering products that align with PCH's requirements and regulatory standards.

2Requirements & Qualifications

Indian exporters aiming to supply PCH and the broader Algerian market must ensure that their products are registered with the Ministry of Health and comply with GMP standards recognized by authorities such as the EU, WHO, or PIC/S. Additionally, products must meet labeling requirements in Arabic and French and adhere to serialization mandates. Establishing a partnership with PCH also requires a thorough understanding of Algeria's regulatory framework and a commitment to maintaining high-quality standards.

3How to Approach

Frequently Asked Questions — Pharmacie Centrale DES Hopitaux (PC

What products does Pharmacie Centrale DES Hopitaux (PC import from India?

Pharmacie Centrale DES Hopitaux (PC imports 4 pharmaceutical products across 2 categories. Top imports: Epirubicin ($250.0K), Mitomycin ($200.0K), Vincristine ($122.6K), Cisplatin ($100.0K).

What is Pharmacie Centrale DES Hopitaux (PC's total pharmaceutical import value?

Pharmacie Centrale DES Hopitaux (PC's total pharmaceutical import value from India is $672.6K, based on 19 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Pharmacie Centrale DES Hopitaux (PC focus on?

Pharmacie Centrale DES Hopitaux (PC imports across 2 categories. The largest: Advanced Oncology (66.9%), Oncology (33.1%).

Get Full Pharmacie Centrale DES Hopitaux (PC Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.

Pharmacie Centrale DES Hopitaux (PC

Pharmacie Centrale DES Hopitaux (PC — Import Portfolio & Supplier Network

What Products Does Pharmacie Centrale DES Hopitaux (PC Import?

Top Products by Import Value

Pharmacie Centrale DES Hopitaux (PC Therapeutic Categories — 2 Specializations